These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27213585)

  • 1. Microsatellite instability derived JAK1 frameshift mutations are associated with tumor immune evasion in endometrioid endometrial cancer.
    Stelloo E; Versluis MA; Nijman HW; de Bruyn M; Plat A; Osse EM; van Dijk RH; Nout RA; Creutzberg CL; de Bock GH; Smit VT; Bosse T; Hollema H
    Oncotarget; 2016 Jun; 7(26):39885-39893. PubMed ID: 27213585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of function JAK1 mutations occur at high frequency in cancers with microsatellite instability and are suggestive of immune evasion.
    Albacker LA; Wu J; Smith P; Warmuth M; Stephens PJ; Zhu P; Yu L; Chmielecki J
    PLoS One; 2017; 12(11):e0176181. PubMed ID: 29121062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1.
    Sveen A; Johannessen B; Tengs T; Danielsen SA; Eilertsen IA; Lind GE; Berg KCG; Leithe E; Meza-Zepeda LA; Domingo E; Myklebost O; Kerr D; Tomlinson I; Nesbakken A; Skotheim RI; Lothe RA
    Genome Med; 2017 May; 9(1):46. PubMed ID: 28539123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frameshift mutations in the bax gene are not involved in development of ovarian endometrioid carcinoma.
    Cao SN; Chang KH; Luthra R; Liu J
    Mod Pathol; 2003 Oct; 16(10):1048-52. PubMed ID: 14559989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAT-26 microsatellite instability does not correlate with the loss of hMLH1 and hMSH2 protein expression in sporadic endometrial cancers.
    Miturski R; Bogusiewicz M; Tarkowski R; Ciotta C; Bignami M; Burnouf D; Jakowicki JA
    Oncol Rep; 2003; 10(4):1039-43. PubMed ID: 12792767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1.
    Rudd ML; Mohamed H; Price JC; O'Hara AJ; Le Gallo M; Urick ME; ; Cruz P; Zhang S; Hansen NF; Godwin AK; Sgroi DC; Wolfsberg TG; Mullikin JC; Merino MJ; Bell DW
    BMC Cancer; 2014 Nov; 14():884. PubMed ID: 25427824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the immune escape phenotype of human gastric cancers with and without high-frequency microsatellite instability.
    Hirata T; Yamamoto H; Taniguchi H; Horiuchi S; Oki M; Adachi Y; Imai K; Shinomura Y
    J Pathol; 2007 Apr; 211(5):516-523. PubMed ID: 17318812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instability.
    Davalos V; Dopeso H; Velho S; Ferreira AM; Cirnes L; Díaz-Chico N; Bilbao C; Ramírez R; Rodríguez G; Falcón O; León L; Niessen RC; Keller G; Dallenbach-Hellweg G; Espín E; Armengol M; Plaja A; Perucho M; Imai K; Yamamoto H; Gebert JF; Díaz-Chico JC; Hofstra RM; Woerner SM; Seruca R; Schwartz S; Arango D
    Oncogene; 2007 Jan; 26(2):308-11. PubMed ID: 16819508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAX somatic frameshift mutations in endometrioid adenocarcinomas of the endometrium: evidence for a tumor progression role in endometrial carcinomas with microsatellite instability.
    Catasús L; Matias-Guiu X; Machin P; Muñoz J; Prat J
    Lab Invest; 1998 Nov; 78(11):1439-44. PubMed ID: 9840618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival.
    Cosgrove CM; Cohn DE; Hampel H; Frankel WL; Jones D; McElroy JP; Suarez AA; Zhao W; Chen W; Salani R; Copeland LJ; O'Malley DM; Fowler JM; Yilmaz A; Chassen AS; Pearlman R; Goodfellow PJ; Backes FJ
    Gynecol Oncol; 2017 Sep; 146(3):588-595. PubMed ID: 28709704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI-associated endometrial carcinoma.
    Kang S; Lee JM; Jeon ES; Lee S; Kim H; Kim HS; Seo SS; Park SY; Sidransky D; Dong SM
    Int J Cancer; 2006 Sep; 119(6):1316-21. PubMed ID: 16619251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers.
    Bertoni F; Codegoni AM; Furlan D; Tibiletti MG; Capella C; Broggini M
    Genes Chromosomes Cancer; 1999 Oct; 26(2):176-80. PubMed ID: 10469457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JAK1 truncating mutations in gynecologic cancer define new role of cancer-associated protein tyrosine kinase aberrations.
    Ren Y; Zhang Y; Liu RZ; Fenstermacher DA; Wright KL; Teer JK; Wu J
    Sci Rep; 2013 Oct; 3():3042. PubMed ID: 24154688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability.
    Vassileva V; Millar A; Briollais L; Chapman W; Bapat B
    Cancer Res; 2002 Jul; 62(14):4095-9. PubMed ID: 12124347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability-high (MSI-H) molecular subtype.
    Brodeur MN; Selenica P; Ma W; Moufarrij S; Dagher C; Basili T; Abu-Rustum NR; Aghajanian C; Zhou Q; Iasonos A; Ellenson LH; Weigelt B; Chui MH
    Mol Oncol; 2024 Oct; 18(10):2356-2368. PubMed ID: 39031567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA Class I Analysis Provides Insight Into the Genetic and Epigenetic Background of Immune Evasion in Colorectal Cancer With High Microsatellite Instability.
    Kawazu M; Ueno T; Saeki K; Sax N; Togashi Y; Kanaseki T; Chida K; Kishigami F; Sato K; Kojima S; Otsuka M; Kawazoe A; Nishinakamura H; Yuka M; Yamamoto Y; Yamashita K; Inoue S; Tanegashima T; Matsubara D; Tane K; Tanaka Y; Iinuma H; Hashiguchi Y; Hazama S; Khor SS; Tokunaga K; Tsuboi M; Niki T; Eto M; Shitara K; Torigoe T; Ishihara S; Aburatani H; Haeno H; Nishikawa H; Mano H
    Gastroenterology; 2022 Mar; 162(3):799-812. PubMed ID: 34687740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression.
    Salvesen HB; Stefansson I; Kretzschmar EI; Gruber P; MacDonald ND; Ryan A; Jacobs IJ; Akslen LA; Das S
    Int J Oncol; 2004 Dec; 25(6):1615-23. PubMed ID: 15547698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of hMSH3 and hMSH6 in ovarian endometrioid carcinoma and relationship with microsatellite instability phenotype.
    Albarracin CT; Silva EG; Malpica A; Luthra R; Liu J
    Oncol Rep; 2004 Dec; 12(6):1217-9. PubMed ID: 15547740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frameshift mutations at coding mononucleotide repeat microsatellites in endometrial carcinoma with microsatellite instability.
    Catasus L; Matias-Guiu X; Machin P; Zannoni GF; Scambia G; Benedetti-Panici P; Prat J
    Cancer; 2000 May; 88(10):2290-7. PubMed ID: 10820351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-plex spatial transcriptomic profiling reveals distinct immune components and the HLA class I/DNMT3A/CD8 modulatory axis in mismatch repair-deficient endometrial cancer.
    Guo J; Tang B; Fu J; Zhu X; Xie W; Wang N; Ding Z; Song Z; Yang Y; Xu G; Xiao X
    Cell Oncol (Dordr); 2024 Apr; 47(2):573-585. PubMed ID: 37847338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.